Jonathan Lisle
Partner
London
T:+44.20.7413.1331
M: +44 7769 142326
E:jlisle@crowell.com

PARTNER Jonathan Lisle is a partner at Crowell & Moring and leads the firm's London Corporate Practice. Jonathan brings extensive experience in cross-border mergers and acquisitions. His practice focuses on general private M&A across all sectors, but he also has particular experience in health care. He was the co-founder of CMS Cameron McKenna's health care group in 2006 and was the EMA head of health care at DLA Piper in 2011-2015.

Jonathan has acted on corporate transactions with deal values up to £10 billion (the largest being a bid for British Energy plc). His clients have included GE Capital (including the sale of the TIP Trailer business across 16 jurisdictions), GE Healthcare, Fidelity, Lebara Mobile, Senior plc, Renova Group, TIP Trailers, HNA Group, John Laing plc (on its £1 billion takeover by Henderson), ITE Group plc, Takeda Pharmaceuticals, Royal Bank of Scotland plc, HSBC, VT Group plc, National Australia Bank, and Survitec Group. He has advised on over 30 health care transactions, including for General Healthcare Group, Spire Healthcare, Ramsay Health Care UK, Nuffield Health, The Priory Group, LGV Capital, and Sovereign Capital.

Click image to enlarge

HEALTHCARE

Crowell & Moring has a market leading Health care practice and its 32 dedicated lawyers? advise on all aspects of Health care transactions and operations both in the U.S. and in Europe.

Our lawyers deliver comprehensive legal solutions to complex business and regulatory challenges, including major corporate transactions such as mergers & acquisitions, joint ventures and outsourcing transactions. We also provide strategic and day-to-day counsel on compliance with applicable legislation, including health insurance regulations and health information privacy and security laws.

Examples of recent matters include advising:

• Humana Inc. in its $35 billion sale by merger to Aetna Inc. (antitrust counsel)

• Health Net, Inc. in its $6 billion sale by merger to Centene Corporation (regulatory counsel)

• Blue Shield of California in its $1.2 billion acquisition of Care1st (regulatory counsel)
• Health Plans (including Aetna, Cigna, Health Net and WellCare) in pharmacy benefit management outsourcing arrangements each involving multiple billions of drug spend per year

• Aetna Inc. in its $405 million acquisition of Active Health Management Inc.

• Health Net, Inc. in its $140 million sale of its Medicare PDP business to CVSCaremark and related commercial matters

• QuadraMed Corporation, a publicly-traded healthcare and hospital information technology company, in its $126 million sale by merger